Dave Wallace, Generics Bulletin executive editor (@davegenerics) 's Twitter Profile
Dave Wallace, Generics Bulletin executive editor

@davegenerics

Generics Bulletin editor Dave Wallace looks at everything that's important to the generics, biosimilars and value-added medicines industries. All views my own.

ID: 1106128939427205120

linkhttps://pharmaintelligence.informa.com/ calendar_today14-03-2019 09:44:24

129 Tweet

131 Takipçi

120 Takip Edilen

Dave Wallace, Generics Bulletin executive editor (@davegenerics) 's Twitter Profile Photo
Dave Wallace, Generics Bulletin executive editor
@davegenerics

4 years ago

In the second part of an exclusive two-part interview with Generics Bulletin, Alvotech founder and chairman Róbert Wessman sets out the firm’s expectations for its rival to Humira as it continues to battle AbbVie in US litigation over its higher-strength adalimumab biosimilar.